CEBPA and neoplasm: However, both tumor DNA sequencing analyses (Archer VARIANTPlex Core Myeloid amplification followed by Illumina sequencing, mean CEBPA coverage 2080x and 3560x) detected no second variant in the CEBPA gene (Table 2, Figure 2), and could not support our hypothesis for solid tumorigenesis in the proband.